3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 4
1
Phase 2
1
Status
Unknown
2
Completed
2
Recruiting
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
33
Neoplasms
16
Prostatic Neoplasms
15
Lung Neoplasms
11
Carcinoma, Hepatocellular
11
Multiple Myeloma
9
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Papillomavirus Infections
6
Pain, Postoperative
6
Neoplasm Metastasis
6
Liver Neoplasms
6
Leukemia, Myeloid, Acute
6
Stomach Neoplasms
5
Recurrence
5
Lymphoma, Non-Hodgkin
4
Kidney Neoplasms
4
Heart Failure
4
Glioma
4
Febrile Neutropenia
4
Carcinoma, Renal Cell
4
Brain Neoplasms
4
Warts
3
Vomiting
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Skin Neoplasms
3
Rectal Neoplasms
3
Pituitary Neoplasms
3
Interventions
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Finasteride
1
Dutasteride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Recruiting
×
Prostatic Hyperplasia
×
Clear all
NCT06001619
2023-08-21
PROMED
Turku University Hospital
Phase 4
Recruiting
100 enrolled